Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia
Michelle A. Borg, PharmD, and Amber Clemmons, PharmD, BCOP
University of Georgia College of Pharmacy and Augusta University Medical Center, Augusta, Georgia
Authors’ disclosures of potential conflicts of interest are found at the end of this article
Michelle A. Borg, PharmD, Augusta University Medical Center, 1120 15th Street, BI-2101, Augusta, GA 30912.
J Adv Pract Oncol 2017;8:647–652 |
© 2017 Harborside Press®
For access to the full length article, please sign in